192 related articles for article (PubMed ID: 38609183)
1. Nr1h4 and Thrb ameliorate ER stress and provide protection in the MPTP mouse model of Parkinson's.
Ahuja N; Gupta S; Arora R; Bhagyaraj E; Tiwari D; Kumar S; Gupta P
Life Sci Alliance; 2024 Jul; 7(7):. PubMed ID: 38609183
[TBL] [Abstract][Full Text] [Related]
2. MPTP-driven NLRP3 inflammasome activation in microglia plays a central role in dopaminergic neurodegeneration.
Lee E; Hwang I; Park S; Hong S; Hwang B; Cho Y; Son J; Yu JW
Cell Death Differ; 2019 Jan; 26(2):213-228. PubMed ID: 29786072
[TBL] [Abstract][Full Text] [Related]
3. ER Stress Induced by Tunicamycin Triggers α-Synuclein Oligomerization, Dopaminergic Neurons Death and Locomotor Impairment: a New Model of Parkinson's Disease.
Cóppola-Segovia V; Cavarsan C; Maia FG; Ferraz AC; Nakao LS; Lima MM; Zanata SM
Mol Neurobiol; 2017 Oct; 54(8):5798-5806. PubMed ID: 27660269
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of miR-124 in MPTP-treated mouse model of Parkinson's disease and MPP iodide-treated MN9D cells modulates the expression of the calpain/cdk5 pathway proteins.
Kanagaraj N; Beiping H; Dheen ST; Tay SS
Neuroscience; 2014 Jul; 272():167-79. PubMed ID: 24792712
[TBL] [Abstract][Full Text] [Related]
5. Dopaminergic neuron-specific deletion of p53 gene is neuroprotective in an experimental Parkinson's disease model.
Qi X; Davis B; Chiang YH; Filichia E; Barnett A; Greig NH; Hoffer B; Luo Y
J Neurochem; 2016 Sep; 138(5):746-57. PubMed ID: 27317935
[TBL] [Abstract][Full Text] [Related]
6. Impaired CBS-H
Yuan YQ; Wang YL; Yuan BS; Yuan X; Hou XO; Bian JS; Liu CF; Hu LF
Brain Behav Immun; 2018 Jan; 67():77-90. PubMed ID: 28774789
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of Drp1 mitochondrial translocation provides neural protection in dopaminergic system in a Parkinson's disease model induced by MPTP.
Filichia E; Hoffer B; Qi X; Luo Y
Sci Rep; 2016 Sep; 6():32656. PubMed ID: 27619562
[TBL] [Abstract][Full Text] [Related]
8. TRPV4 contributes to ER stress and inflammation: implications for Parkinson's disease.
Liu N; Bai L; Lu Z; Gu R; Zhao D; Yan F; Bai J
J Neuroinflammation; 2022 Jan; 19(1):26. PubMed ID: 35093118
[TBL] [Abstract][Full Text] [Related]
9. 2',3'-Dideoxycytidine Protects Dopaminergic Neurons in a Mouse Model of Parkinson's Disease.
Niu J; Xiong J; Hu D; Zeng F; Nie S; Mao S; Wang T; Zhang Z; Zhang Z
Neurochem Res; 2017 Oct; 42(10):2996-3004. PubMed ID: 28631231
[TBL] [Abstract][Full Text] [Related]
10. Dopamine receptor D2 on CD4
Liu Z; Zhai XR; Du ZS; Xu FF; Huang Y; Wang XQ; Qiu YH; Peng YP
Brain Behav Immun; 2021 Nov; 98():110-121. PubMed ID: 34403737
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotective effects of 2,4-dinitrophenol in an acute model of Parkinson's disease.
Lee Y; Heo G; Lee KM; Kim AH; Chung KW; Im E; Chung HY; Lee J
Brain Res; 2017 May; 1663():184-193. PubMed ID: 28322751
[TBL] [Abstract][Full Text] [Related]
12. DJ-1-dependent protective activity of DJ-1-binding compound no. 23 against neuronal cell death in MPTP-treated mouse model of Parkinson's disease.
Takahashi-Niki K; Inafune A; Michitani N; Hatakeyama Y; Suzuki K; Sasaki M; Kitamura Y; Niki T; Iguchi-Ariga SM; Ariga H
J Pharmacol Sci; 2015 Mar; 127(3):305-10. PubMed ID: 25837927
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Potential Neuroprotective Effects of Vanillin Against MPP
Rani L; Ghosh B; Ahmad MH; Mondal AC
Mol Neurobiol; 2023 Aug; 60(8):4693-4715. PubMed ID: 37145378
[TBL] [Abstract][Full Text] [Related]
14. Silibinin prevents dopaminergic neuronal loss in a mouse model of Parkinson's disease via mitochondrial stabilization.
Lee Y; Park HR; Chun HJ; Lee J
J Neurosci Res; 2015 May; 93(5):755-65. PubMed ID: 25677261
[TBL] [Abstract][Full Text] [Related]
15. Tauroursodeoxycholic acid prevents MPTP-induced dopaminergic cell death in a mouse model of Parkinson's disease.
Castro-Caldas M; Carvalho AN; Rodrigues E; Henderson CJ; Wolf CR; Rodrigues CM; Gama MJ
Mol Neurobiol; 2012 Oct; 46(2):475-86. PubMed ID: 22773138
[TBL] [Abstract][Full Text] [Related]
16. Quercetin Protects against MPP
Lin ZH; Liu Y; Xue NJ; Zheng R; Yan YQ; Wang ZX; Li YL; Ying CZ; Song Z; Tian J; Pu JL; Zhang BR
Oxid Med Cell Longev; 2022; 2022():7769355. PubMed ID: 36105483
[TBL] [Abstract][Full Text] [Related]
17. Cholesterol contributes to dopamine-neuronal loss in MPTP mouse model of Parkinson's disease: Involvement of mitochondrial dysfunctions and oxidative stress.
Paul R; Choudhury A; Kumar S; Giri A; Sandhir R; Borah A
PLoS One; 2017; 12(2):e0171285. PubMed ID: 28170429
[TBL] [Abstract][Full Text] [Related]
18. IL-17A exacerbates neuroinflammation and neurodegeneration by activating microglia in rodent models of Parkinson's disease.
Liu Z; Qiu AW; Huang Y; Yang Y; Chen JN; Gu TT; Cao BB; Qiu YH; Peng YP
Brain Behav Immun; 2019 Oct; 81():630-645. PubMed ID: 31351185
[TBL] [Abstract][Full Text] [Related]
19. Integrative multilevel exploration of the mechanism by which Er-Zhi-Wan alleviates the Parkinson's disease (PD)-like phenotype in the MPTP-induced PD mouse model.
Pan B; Niu B; He Y; Zhou C; Xia C
Biomed Pharmacother; 2023 Sep; 165():115021. PubMed ID: 37348406
[TBL] [Abstract][Full Text] [Related]
20. Dendrobine inhibits dopaminergic neuron apoptosis via MANF-mediated ER stress suppression in MPTP/MPP
Li QM; Li X; Su SQ; Wang YT; Xu T; Zha XQ; Pan LH; Shang ZZ; Zhang FY; Luo JP
Phytomedicine; 2022 Jul; 102():154193. PubMed ID: 35636177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
